🇺🇸 FDA
Company

Vanda

Vanda Pharmaceuticals

VNDA pharma USA

Quick answer

Vanda is a pharma company (VNDA) headquartered in WASHINGTON, DC, USA with 24 tracked pipeline programs.

Pipeline (24)

project

20 mg VEC-162

Insomnia

Phase 3 · small_molecule · completed

1 trials project

750 mg Imsidolimab

Generalized Pustular Psoriasis

Phase 3 · small_molecule · completed

1 trials project

Double-blind 200 mg imsidolimab

Generalized Pustular Psoriasis

Phase 3 · small_molecule · terminated

1 trials project

Iloperidone

Bipolar I Disorder

Phase 3 · small_molecule · completed

2 trials project

Milsaperidone

Major Depressive Disorder (MDD)

Phase 3 · small_molecule · active

1 trials project

Ponesimod

Moderate-to-severe Chronic Plaque Psoriasis

Phase 3 · small_molecule · active

1 trials project

Tasimelteon

Sleep Wake Disorders

Phase 3 · small_molecule · active

2 trials project

Tasimelteon

Jet Lag Type Insomnia

Phase 3 · small_molecule · completed

1 trials project

Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension

Autism Spectrum Disorder

Phase 3 · small_molecule · active

1 trials project

Tasimelteon Oral Suspension

Insomnia Disorder

Phase 3 · small_molecule · active

1 trials project

Tradipitant

Coronavirus Infection

Phase 3 · small_molecule · active

1 trials project

Tradipitant

Atopic Dermatitis

Phase 3 · small_molecule · completed

3 trials project

Tradipitant

Nausea and Vomiting

Phase 3 · small_molecule · active

1 trials project

Tradipitant

Idiopathic Gastroparesis

Phase 3 · small_molecule · active

2 trials project

Tradipitant

Motion Sickness

Phase 3 · small_molecule · active

4 trials project

VEC-162 20 mg

Primary Insomnia

Phase 3 · small_molecule · completed

1 trials project

VQW-765

Social Anxiety Disorder (SAD)

Phase 3 · small_molecule · active

1 trials project

tasimelteon

Non 24 Hour Sleep Wake Disorder

Phase 3 · small_molecule · active

4 trials project

tasimelteon

Major Depressive Disorder

Phase 3 · small_molecule · completed

1 trials project

tasimelteon

Smith-Magenis Syndrome

Phase 3 · small_molecule · completed

1 trials project

Iloperidone

Parkinson Disease Psychosis

Phase 2 · small_molecule · terminated

1 trials project

Iloperidone crystalline formulation

Schizophrenia

Phase 2 · small_molecule · completed

1 trials project

Imsidolimab

Ichthyosis

Phase 2 · small_molecule · terminated

1 trials project

Imsidolimab

Hidradenitis Suppurativa

Phase 2 · mab · completed

1 trials

Drugs (5)

drug

iloperidone

ILOPERIDONE

 drug

milsaperidone

BYSANTI

 drug

ponesimod

PONVORY

 drug

tasimelteon

HETLIOZ

 drug

tradipitant

NEREUS

Patents (8)

patent

US 12427132

Method of improving sleep

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12419869

Methods of treating multiple sclerosis

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12409167

Pharmaceutical combination comprising a selective S1P1 receptor agonist

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12403134

Method for improving or enhancing cognition

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12357616

Methods of treating multiple sclerosis

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12336980

Dosing regimen for a selective S1P1 receptor agonist

Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318375

Method of treatment with tradipitant

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12201604

Treatment of circadian rhythm disorders

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)